Clinical research in Hungary
Hungary is a landlocked country located in the heart of Central Europe. Budapest is the capital and largest city, and arguably one of Europe's most attractive cities, with it's medieval castles, spectacular views over the Danube river, and a thriving nightlife.
A European Union member since 2004, Hungary has its clinical trial legislation harmonized with the European standards. The approval process is relatively short and very straightforward with the single authority being responsible for aspects of drug profuction, registration, pharmacovigilance, etc.
When it comes to the number of clinical trials, Hungary is among the European leaders.
The diseases with the highest incidence in Hungary are:
- malignant neoplasm (especially high is the incidence of respiratory and colorectal cancers
- cardiovascular (ischemic heart disease, strokes, myocarditis and other cardiovascular diseases)
- diarrheal diseases
- lower respiratory illnesses
Hungary has a tax-funded universal healthcare system. Four medical universities (Semmelweis University, Debrecen University, Szeged University & Pécs University) with their clinics and a network of major specialized hospitals stand in the center of the potential clinical sites network.
Key local authority: Ministry of Health of Hungary